logo
ResearchBunny Logo
The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study

Medicine and Health

The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study

G. R. Md, B. R. B. M. Mba, et al.

This study by Gordana Rasic MD and colleagues reveals how the COVID-19 pandemic influenced treatment initiation timelines for hepatocellular carcinoma patients. While the results indicated a statistically shorter time in 2020, the findings suggest that certain vulnerable populations faced significant treatment delays during this challenging period.

00:00
Playback language: English
Abstract
This study investigated the impact of the COVID-19 pandemic on time to treatment initiation (TTI) for hepatocellular carcinoma (HCC) using the National Cancer Database. While a statistically significant shorter median TTI was observed during the COVID year (2020) compared to pre-COVID years (2017-2019), this difference was not clinically significant. However, the study revealed that vulnerable patient populations (Black race, Hispanic ethnicity, and those with uninsured/Medicaid/Other Government insurance) experienced increased TTI and treatment delays.
Publisher
Ann Surg Oncol
Published On
Apr 26, 2023
Authors
Gordana Rasic MD, Brendin R Beaulieu-Jones MD, MBA, Sophie H Chung MD, Kelsey S Romatoski MD, Kelly Kenzik PhD, Sing Chau Ng MS, Jennifer F Tseng MD, MPH, Teviah E Sachs MD, MPH
Tags
COVID-19
hepatocellular carcinoma
treatment initiation
National Cancer Database
health disparities
vulnerable populations
time to treatment initiation
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny